Subclinical alveolitis in immunologic systemic disorders.

Area of Science:

• Pulmonary Medicine
• Rheumatology
• Immunology

Background:

• Subclinical alveolitis is common in systemic immune disorders but its significance varies by disease.
• Pulmonary involvement is infrequent in extrathoracic granulomatosis (e.g., Crohn's disease, primary biliary cirrhosis).
• Subclinical alveolitis in these conditions may reflect a systemic immune process.

Purpose of the Study:

• To investigate the varied significance of subclinical alveolitis in different immunologic systemic disorders.
• To explore the association between subclinical alveolitis and lung parenchymal abnormalities, particularly interstitial lung disease (ILD).
• To determine if early detection of subclinical alveolitis can identify patients at risk for developing ILD.

Main Methods:

• Review of findings in patients with various immunologic systemic disorders.
• Correlation of subclinical alveolitis with clinical presentation and pulmonary involvement.
• Assessment of lung parenchyma abnormalities using CT scans in specific conditions like progressive systemic sclerosis.

Main Results:

• Subclinical alveolitis in Crohn's disease and primary biliary cirrhosis may represent systemic inflammation rather than direct lung disease.
• In collagen-vascular diseases, especially progressive systemic sclerosis, subclinical alveolitis is often linked to lung parenchymal changes on CT.
• This association suggests subclinical alveolitis may precede or coincide with the development of interstitial lung disease (ILD).

Conclusions:

• The clinical significance of subclinical alveolitis is disease-dependent within immunologic systemic disorders.
• Subclinical alveolitis in collagen-vascular diseases, particularly progressive systemic sclerosis, is a potential marker for developing ILD.
• Close patient monitoring is essential to ascertain if subclinical alveolitis predicts ILD and if early detection aids risk stratification.